Calcium plus Vitamin D Supplementation and the Risk of Colorectal CancerJean Wactawski‐Wende, JoAnn E. Manson, Denise E. Bonds et al.|New England Journal of Medicine|2006Cited by 985
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist PegvisomantPeter Trainer, John A. Scarlett, William M Drake et al.|New England Journal of Medicine|2000Cited by 874
Vitamin D Supplementation and Prevention of Type 2 DiabetesAnastassios G. Pittas, Myrlene A. Staten, Bess Dawson‐Hughes et al.|New England Journal of Medicine|2019Cited by 662
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistAart Jan van der Lely, Michael O. Thorner, R. Kent Hutson et al.|The Lancet|2001Cited by 643
Use of Thiazolidinediones and Risk of Heart Failure in People With Type 2 DiabetesThomas E. Delea, Lawrence S. Phillips, John Edelsberg et al.|Diabetes Care|2003Cited by 216